We are live on ! Find out more
DP

Dearborn Partners Portfolio holdings

AUM $1.85B
1-Year Est. Return 6.59%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+6.59%
3 Year Est. Return
+44.33%
5 Year Est. Return
+68.05%
10 Year Est. Return
+241.41%
AUM
$2.39B
AUM Growth
-$77M
Cap. Flow
-$31.6M
Cap. Flow %
-1.33%
Top 10 Hldgs %
27.24%
Holding
278
New
12
Increased
90
Reduced
122
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 25.72%
2 Industrials 14.79%
3 Financials 10.99%
4 Healthcare 10.98%
5 Consumer Discretionary 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFA icon
251
iShares MSCI EAFE ETF
EFA
$78B
$215K 0.01%
2,842
BMY icon
252
Bristol-Myers Squibb
BMY
$131B
$212K 0.01%
+3,755
New +$210K
BAX icon
253
Baxter International
BAX
$13.5B
$212K 0.01%
7,258
IEX icon
254
IDEX
IEX
$16.9B
$209K 0.01%
1,001
XLRE icon
255
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.54B
$209K 0.01%
+5,131
New +$222K
DOV icon
256
Dover
DOV
$27.6B
$203K 0.01%
+1,081
New +$211K
CINF icon
257
Cincinnati Financial
CINF
$27B
$202K 0.01%
+1,403
New +$205K
IGC icon
258
IGC Pharma
IGC
$26.4M
$36.8K ﹤0.01%
109,401
-7,000
-6% -$2.62K
AMAT icon
259
Applied Materials
AMAT
$409B
-1,404
Closed -$284K
AMD icon
260
Advanced Micro Devices
AMD
$802B
-3,228
Closed -$530K
BABA icon
261
Alibaba
BABA
$292B
-2,130
Closed -$226K
BCE icon
262
BCE
BCE
$20B
-14,015
Closed -$488K
CVS icon
263
CVS Health
CVS
$134B
-7,013
Closed -$441K
ELV icon
264
Elevance Health
ELV
$81.7B
-57,547
Closed -$29.9M
FSLR icon
265
First Solar
FSLR
$22.6B
-2,100
Closed -$524K
GGG icon
266
Graco
GGG
$12.8B
-2,659
Closed -$233K
GPCR icon
267
Structure Therapeutics
GPCR
$3.39B
-4,600
Closed -$202K
IBTF
268
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
-16,703
Closed -$391K
NEM icon
269
Newmont
NEM
$99.2B
-5,500
Closed -$294K
NOC icon
270
Northrop Grumman
NOC
$75.8B
-402
Closed -$212K
SJM icon
271
J.M. Smucker
SJM
$12.9B
-1,817
Closed -$220K
SPG icon
272
Simon Property Group
SPG
$74.8B
-1,652
Closed -$279K
TMO icon
273
Thermo Fisher Scientific
TMO
$210B
-483
Closed -$299K
TROW icon
274
T. Rowe Price
TROW
$24.1B
-1,851
Closed -$202K
XBI icon
275
State Street SPDR S&P Biotech ETF
XBI
$10B
-2,705
Closed -$267K

Similar funds

Dearborn Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Dearborn Partners held 278 positions worth $2.39B, down 3.1% from $2.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dearborn Partners's Q4 2024 filing shows 12 new, 90 increased, 122 reduced and 19 closed positions. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 22,655 shares worth $517K. The largest sale was Elevance Health, an estimated $29.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Financials.

  • Dearborn Partners's largest Q4 2024 buy was iShares iBonds Dec 2029 Term Corporate ETF: 22,655 shares worth $517K.
  • Dearborn Partners added most to Corteva in Q4 2024, an estimated $31.8M increase.
  • Dearborn Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $20.6M.
  • Dearborn Partners fully exited Elevance Health in Q4 2024, selling an estimated $29.9M.
  • Dearborn Partners's ten largest holdings make up 27% of its $2.39B portfolio in Q4 2024.
  • Dearborn Partners opened 12 new positions and closed 19 in Q4 2024.
  • Dearborn Partners's portfolio value fell 3.1% quarter-over-quarter to $2.39B.

Based on Dearborn Partners's 13F filing for Q4 2024, filed 7 Feb 2025.